Fusion genes: A promising tool combating against cancer

Area of Science:

• Genomics
• Cancer Biology
• Bioinformatics

Background:

• Fusion genes have long been recognized for their critical roles in tumorigenesis.
• Advances in sequencing and computational biology have accelerated the identification of fusion genes.
• The discovery of splicing-based fusions in normal tissues challenges traditional understanding and presents new medical avenues.

Purpose of the Study:

• To re-evaluate current knowledge on fusion genes for accelerated clinical translation.
• To categorize fusion events by generation mechanisms, oncological consequences, and clinical implications.
• To provide system-level insights into fusion gene occurrence across tumors and guide future research.

Main Methods:

• Review and synthesis of existing literature on fusion genes.
• Categorization of fusion events based on mechanistic, oncological, and clinical criteria.
• System-level analysis of fusion gene occurrence across diverse tumor types.

Main Results:

• Fusion genes are specific to neoplastic tissues and play diverse roles in carcinogenesis.
• Understanding fusion gene mechanisms and implications is crucial for targeted cancer therapy.
• The presence of fusion genes in normal tissues opens novel diagnostic and therapeutic possibilities.

Conclusions:

• Fusion genes represent promising biomarkers and therapeutic targets in oncology.
• A comprehensive understanding of fusion gene biology is essential for advancing cancer treatment.
• Further research into understudied fusion gene niches may uncover future therapeutic strategies.